Chronic lymphocytic thyroiditis (CLT), also known as Hashimoto thyroiditis, is an autoimmune disease characterized by lymphocytic infiltration of the thyroid gland, with the concomitant production of autoantibodies to thyroid antigens, primarily thyroglobulin and/or thyroperoxidase (TPO), formerly known as microsomal antigen (1). Although few epidemiological data are available, the prevalence of CLT is estimated to be 1 in 1,000 people, with an incidence of 0.2 to 2% and a female-to-male ratio of about 18:1 (1). Clinical signs and symptoms manifest slowly and may involve many systems of the body (1). Accumulations of hydrophilic mucoproteins with edema, a condition called myxedema, affects skin and connective tissue and can affect the appearance of the individual. Lethargy may ensue, with a loss of mental acuity. Systems commonly affected are the gastrointestinal tract, the hemopoietic system, the endocrine system, and the urogenital system (1). Enlargement of the thyroid gland due to lymphocyte invasion, called goiter, is a frequent manifestation, although there is an atrophic variation. Demonstration of autoantibodies to the thyroid antigens aids in the diagnosis of CLT, distinguishing it from other causes of hypothyroidism.

Endocrinopathies: chronic thyroiditis, addison disease, pernicious anemia, graves’ disease, diabetes, and hypophysitis / L., De Vincentiis; A., Ricciuti; A., De Remigis; Caturegli, ; Burek, P. C. L.; Rose, N. R.; Barbesino, Giuseppe; Wang, Jian; Steck, ANDREA K.; Eisenbarth, GEORGE S.; LIPING YU, †; DE VINCENTIIS, Ludovica; Ricciuti, Adriana; DE REMIGIS, Alessandra; PATRIZIO CATUREGLI, And. - STAMPA. - (2016). [10.1128/9781555818722].

Endocrinopathies: chronic thyroiditis, addison disease, pernicious anemia, graves’ disease, diabetes, and hypophysitis

LUDOVICA DE VINCENTIIS
Membro del Collaboration Group
;
2016

Abstract

Chronic lymphocytic thyroiditis (CLT), also known as Hashimoto thyroiditis, is an autoimmune disease characterized by lymphocytic infiltration of the thyroid gland, with the concomitant production of autoantibodies to thyroid antigens, primarily thyroglobulin and/or thyroperoxidase (TPO), formerly known as microsomal antigen (1). Although few epidemiological data are available, the prevalence of CLT is estimated to be 1 in 1,000 people, with an incidence of 0.2 to 2% and a female-to-male ratio of about 18:1 (1). Clinical signs and symptoms manifest slowly and may involve many systems of the body (1). Accumulations of hydrophilic mucoproteins with edema, a condition called myxedema, affects skin and connective tissue and can affect the appearance of the individual. Lethargy may ensue, with a loss of mental acuity. Systems commonly affected are the gastrointestinal tract, the hemopoietic system, the endocrine system, and the urogenital system (1). Enlargement of the thyroid gland due to lymphocyte invasion, called goiter, is a frequent manifestation, although there is an atrophic variation. Demonstration of autoantibodies to the thyroid antigens aids in the diagnosis of CLT, distinguishing it from other causes of hypothyroidism.
2016
Manual of Molecular and Clinical Laboratory Immunology, Eighth Edition
9781555818715
9781555818722
Pituitary; antibodies; autoimmune; hypophysitis; endocrine
02 Pubblicazione su volume::02a Capitolo o Articolo
Endocrinopathies: chronic thyroiditis, addison disease, pernicious anemia, graves’ disease, diabetes, and hypophysitis / L., De Vincentiis; A., Ricciuti; A., De Remigis; Caturegli, ; Burek, P. C. L.; Rose, N. R.; Barbesino, Giuseppe; Wang, Jian; Steck, ANDREA K.; Eisenbarth, GEORGE S.; LIPING YU, †; DE VINCENTIIS, Ludovica; Ricciuti, Adriana; DE REMIGIS, Alessandra; PATRIZIO CATUREGLI, And. - STAMPA. - (2016). [10.1128/9781555818722].
File allegati a questo prodotto
File Dimensione Formato  
De Vincentiis_Enocronopathies.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 676.35 kB
Formato Adobe PDF
676.35 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1120553
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact